Intravenous milrinone is no better than standard therapy for people admitted with acute exacerbation of chronic heart failure

M. Cuffe, R. Califf, K. Adams, R. Benza, R. Bourge, W. Colucci, B. Massie, C. O'Connor, I. Pina, R. Quigg, M. Silver, Mihai Gheorghiade*, Marcus G. Hennersdorf

*Corresponding author for this work

Research output: Contribution to journalShort survey

Original languageEnglish (US)
Pages (from-to)154-155
Number of pages2
JournalEvidence-based Cardiovascular Medicine
Volume6
Issue number4
DOIs
StatePublished - Jan 1 2002

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Cuffe, M. ; Califf, R. ; Adams, K. ; Benza, R. ; Bourge, R. ; Colucci, W. ; Massie, B. ; O'Connor, C. ; Pina, I. ; Quigg, R. ; Silver, M. ; Gheorghiade, Mihai ; Hennersdorf, Marcus G. / Intravenous milrinone is no better than standard therapy for people admitted with acute exacerbation of chronic heart failure. In: Evidence-based Cardiovascular Medicine. 2002 ; Vol. 6, No. 4. pp. 154-155.
@article{0ff689097fd04a74908fc551d0bd4296,
title = "Intravenous milrinone is no better than standard therapy for people admitted with acute exacerbation of chronic heart failure",
author = "M. Cuffe and R. Califf and K. Adams and R. Benza and R. Bourge and W. Colucci and B. Massie and C. O'Connor and I. Pina and R. Quigg and M. Silver and Mihai Gheorghiade and Hennersdorf, {Marcus G.}",
year = "2002",
month = "1",
day = "1",
doi = "10.1054/ebcm.2002.0490",
language = "English (US)",
volume = "6",
pages = "154--155",
journal = "Evidence-based Cardiovascular Medicine",
issn = "1361-2611",
publisher = "Churchill Livingstone",
number = "4",

}

Cuffe, M, Califf, R, Adams, K, Benza, R, Bourge, R, Colucci, W, Massie, B, O'Connor, C, Pina, I, Quigg, R, Silver, M, Gheorghiade, M & Hennersdorf, MG 2002, 'Intravenous milrinone is no better than standard therapy for people admitted with acute exacerbation of chronic heart failure', Evidence-based Cardiovascular Medicine, vol. 6, no. 4, pp. 154-155. https://doi.org/10.1054/ebcm.2002.0490

Intravenous milrinone is no better than standard therapy for people admitted with acute exacerbation of chronic heart failure. / Cuffe, M.; Califf, R.; Adams, K.; Benza, R.; Bourge, R.; Colucci, W.; Massie, B.; O'Connor, C.; Pina, I.; Quigg, R.; Silver, M.; Gheorghiade, Mihai; Hennersdorf, Marcus G.

In: Evidence-based Cardiovascular Medicine, Vol. 6, No. 4, 01.01.2002, p. 154-155.

Research output: Contribution to journalShort survey

TY - JOUR

T1 - Intravenous milrinone is no better than standard therapy for people admitted with acute exacerbation of chronic heart failure

AU - Cuffe, M.

AU - Califf, R.

AU - Adams, K.

AU - Benza, R.

AU - Bourge, R.

AU - Colucci, W.

AU - Massie, B.

AU - O'Connor, C.

AU - Pina, I.

AU - Quigg, R.

AU - Silver, M.

AU - Gheorghiade, Mihai

AU - Hennersdorf, Marcus G.

PY - 2002/1/1

Y1 - 2002/1/1

UR - http://www.scopus.com/inward/record.url?scp=3142664683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142664683&partnerID=8YFLogxK

U2 - 10.1054/ebcm.2002.0490

DO - 10.1054/ebcm.2002.0490

M3 - Short survey

VL - 6

SP - 154

EP - 155

JO - Evidence-based Cardiovascular Medicine

JF - Evidence-based Cardiovascular Medicine

SN - 1361-2611

IS - 4

ER -